中国结核病数字服药依从性技术应用指南  

Evidence-based guidelines for application of digital adherence technology in tuberculosis medication management in China

作　　者：中国防痨协会结核病控制专业分会 中国防痨协会青年分会 《中国防痨杂志》编辑委员会 沈鑫[2] 吴哲渊[2] 肖文静 秦楠 王嘉雯 张国钦[4] 周琳[5] Tuberculosis Control Branch of Chinese Antituberculosis Association;The Youth Branch of Chinese Antituberculosis Association;Editorial Board of Chinese Journal of Antituberculosis

机构地区：[1]不详 [2]上海市疾病预防控制中心 [3]广东省结核病控制中心 [4]天津市疾病预防控制中心 [5]浙江省疾病预防控制中心

出　　处：《中国防痨杂志》2025年第4期385-397,共13页Chinese Journal of Antituberculosis

基　　金：上海市加强公共卫生体系建设三年行动计划(2023—2025年)(GWVI-11.1-05,GWVI-11.2-XD07);2023年东方英才计划拔尖项目;国家疾病预防控制局-公共卫生人才培养支持项目。

摘　　要：及时发现活动性结核病患者及结核分枝杆菌潜伏感染者并开展针对性治疗是控制结核病流行的重要手段。数字依从性技术(digital adherence technology,DAT)利用数字工具辅助卫生服务提供者监测和促进结核病患者和预防性服药者规范服药,可提高服药依从性。本指南系统总结了我国结核病防控领域已经应用的视频督导、电子药盒、手机APP、手机短信等DAT特点和实践证据,提出了应用DAT辅助抗结核治疗和结核病预防性治疗管理的建议,以期为各地利用DAT完善和优化结核病服药管理策略提供循证依据。Timely identification of active tuberculosis(TB)patients and individuals with latent tuberculosis infection(LTBI),followed by targeted treatment,constitutes a critical strategy for TB epidemic control.Digital adherence technology(DAT)utilizes digital tools to assist healthcare providers in monitoring and promoting medication compliance among TB patients and those undergoing preventive treatment,thereby enhancing therapeutic adherence.This guideline systematically summarized the characteristics and practical evidence of DAT currently implemented in China’s TB prevention and control efforts,including video-observed therapy,electronic medication monitors,mobile applications,and SMS reminders.It further proposes recommendations for the application of DAT in supporting anti-TB treatment and TB preventive therapy,aiming to offer evidence-based guidance for the optimization and refinement of TB medication management strategies using DAT across various regions.

关 键 词：结核 自我遵嘱服药 疾病管理 数字依从性技术 总结性报告(主题) 

分 类 号：R52[医药卫生—内科学]